Cardiac PET. John Buscombe

Similar documents
Cardiac NM. John Buscombe

PET myocard perfusion & viability Riemer Slart

Cardiac Imaging Tests

Rational use of imaging for viability evaluation

SPECT CT Current Status and Future Direction Nuclear Cardiology

NUCLEAR CARDIOLOGY UPDATE

PET for the Evaluation of Myocardial Viability

The Role of Nuclear Imaging in Heart Failure

Myocardial viability testing. What we knew and what is new

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

SPECT or PET for Cardiovascular Screening in High-Risk Patients

Typical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?

Advantages of PET Myocardial Imaging

Conflict of Interest Disclosure

Positron emission tomography and molecular imaging

CHRONIC CAD DIAGNOSIS

Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN

Medical imaging X-ray, CT, MRI, scintigraphy, SPECT, PET Györgyi Műzes

CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82

Conflict of Interest Disclosure

Η Πυρηνική Καρδιολογία Το 2017 ΟΜΑΔΑ ΕΡΓΑΣΙΑΣ ΑΠΕΙΚΟΝΙΣΤΙΚΩΝ ΤΕΧΝΙΚΩΝ

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI

Zahid Rahman Khan, MD(USA), MS Diplomate American Board of Nuclear Medicine Consultant t Nuclear Medicine

General Cardiovascular Magnetic Resonance Imaging

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

Myocardial Perfusion: Positron Emission Tomography

Radiologic Assessment of Myocardial Viability

Photon Attenuation Correction in Misregistered Cardiac PET/CT

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging

Le FDG dans l évaluation de la viabilité : Quelle place par rapport aux autres traceurs?

Molecular Imaging of Coronary Plaques

The Role of SPECT/ PET

Medical Policy. MP Cardiac Applications of Positron Emission Tomography Scanning

Current Tracers. João V. Vitola, MD, PhD. Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος

SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin

Reversible defect of 123 I-15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid indicates residual viability within infarct-related area

Functional aspects of anatomical imaging techniques

Evidence for myocardial CT perfusion imaging in the diagnosis of hemodynamically significant coronary artery disease

Gated blood pool ventriculography: Is there still a role in myocardial viability?

Pearls & Pitfalls in nuclear cardiology

Positron Emission Tomography Computed Tomography (PET/CT)

Cardiac Positron Emission Tomography

Disclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview

State-of-the-Art SPECT/CT: Cardiac Imaging

Welcome! To submit questions during the presentation: or Text:

Nuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE.

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

COMENIUS-Project: SM&CLIL Radiation & Medicine

Value of Assessment of Viable and Ischemic Myocardium and Techniques Such as MRI, Radionuclide Imaging

PET and PET/CT in CLINICAL CARDIOLOGY

Diabetes and Occult Coronary Artery Disease

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)

Biases affecting tumor uptake measurements in FDG-PET

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Hybrid Imaging Improving Nuclear Cardiology Practice

Cardial MRI; Approaching the Level of Gold Standard for Viability Assessment

The Value of Stress MRI in Evaluation of Myocardial Ischemia

45 Hr PET Registry Review Course

Imaging of the Heart Todd Tessendorf MD FACC

Fellows on this rotation are expected to attend nuclear conferences and multimodality imaging conference.

Update in Nuclear Cardiology: Patient-Centered Imaging Radiation Dose Reduction

I have no financial disclosures

Positron emission tomography Medicare Services Advisory Committee

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Summary Protocol ISRCTN / NCT REVIVED-BCIS2 Summary protocol version 4, May 2015 Page 1 of 6

CT Perfusion. U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging

New Stable Chest Pain Guidance in the UK NICE to have, difficult to implement

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Cardiac Diagnostics Workshop. Lori Savard NP Cardiology Update 2015

An Epidemic of Heart Disease The Silent Killer. Professor Mike Kirby FRCP University of Hertfordshire Institute of Diabetes for Older People

MD F A F C A C MAS A N S C

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

Radionuclides in Medical Imaging. Danielle Wilson

Stress only Perfusion Imaging

Coronary Revascularization in Patients witj Severe LV Dysfunction.: Is the concept of viability still viable?

Viability Testing Using Dynamic Echocardiography

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice

CMR stress Perfusion: what's new?

CT or PET/CT for coronary artery disease

A Snapshot on Nuclear Cardiac Imaging

Magnetic Resonance Imaging (MRI) for the Assessment of Myocardial Viability

Ischaemic heart disease. IInd Chair and Clinic of Cardiology

Myocardial perfusion scintigraphy using rubidium-82 positron emission tomography

Rubidium-82 myocardial perfusion PET/CT

María del Pilar Garrido Ruiz Teresa Mendoza Dobaño Cristian Jesús Lucena Morales

Microvascular disease Prevalence and Management

Non-invasive images of the myocardium

How to investigate (Cardiac) Chest Pain

Non Invasive Diagnostic Modalities for Coronary Artery Disease. Dr. Amitesh Aggarwal

Cardiovascular Imaging Endpoints in Oncology Clinical Trials

RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING

PHYSICS 2: HSC COURSE 2 nd edition (Andriessen et al) CHAPTER 20 Radioactivity as a diagnostic tool (pages 394-5)

Positron emission tomography myocardial perfusion and glucose metabolism imaging

Molecular Imaging and the Brain

Imaging and heart failure

Transcription:

Cardiac PET John Buscombe

Why PET? Improved resolution-not really required in cardiology Improved sensitivity this may be important-financially as reduced acquisition time Improved attenuation correction-good Look at metabolism-could be very good

PET-CT New technology Combines functional information-pet anatomical information-ct Machine able to perform both studies in single imaging episode PET imaging depends on positron decay

PET Positron Emission Tomography Positrons positively charged electrons Travel 0.001-1mm hit electron Annihilate e=mc 2 2 x 511 kev gammas produced travel at 180 degrees Detected by a ring of detectors Many used in cancer imaging

Positron annihilation

PET detection

PET-CT scanner

Inside a PET-CT scanner

Time of flight Normally PET uses co-incidence event PET systems can only determine the line along which event occurred If resolution fast enough (eg <600ps) can detect different times that the 511keV arrives at detector so can determine site of origin Seems to be of particular use in more obese patients Also can reduce activity required eg from 400-200MBq F-18 FDG

Time of Flight Normal single event recorded Time of flight both events recorded

High quality image in obese patient

F-18 FDG Most commonly available PET radiopharamceutical Uptake dependent on glucose drive in cells Related to hypoxia Glucose to lactate (no O 2 ) = 4ATP per molecule Glucose to Krebs cycle =32 ATP per molecule So ischaemic tissue needs lots of glucose but remember in diabetics competitive uptake so need blood glucose <6mmol/l

Viability In patients with severe ischaemia identification of viable heart very important Revascularisation may result in improvement in flow and over time return of function Prognosis dependent on LVEF in these patients is viable myocardium not improved 32% 1 year survival vs 7% if improved (Dy Carli et al JTCS 1998) F-18 FDG can find that viability

Perfusion and viability Viability found with F-18 FDG (where uptake may be increased in severe ischaemia) How about perfusion N-13 H 3 Rb-82 However though not perfect can use single photon for perfusion

SPET and PET

FDG in action Wu et al Kyoto JNM 2007 Looked at 41 patients with severe IHD Using Tl-201/FDG PET mismatches identified (heart divided into 17 segments) 394 viabible segments per heart were identified in 31 patients 29 had CABG, 76% of these had an improvement of >5% in LVEF

FDG in viability Slart et al Groningen JNC 2006 213 segments in 31 patients (17 segments per patient) were imaged with F-18 FDG before and just after CABG An increase in F-18 FDG uptake of more than 50% post surgery predicted improvement in LVEF in 93% of cases (specificity 85%)

Comparing NH 3 and F-18 FDG Slart et al Groningen EJNMMI 2006 Used combination of NH3 and F-18 FDG PET to determine areas of viability (reduced NH 3 with normal or raised F-18 FDG) or normal NH 3 but raised F-18 FDG) 47 patients with severe IHD In 90% of these PET predicted an improved LVEF post surgery

What can we see What follows is a series of perfusion maps of perfusion and viability Available on line from Bringham and Womens s hospital in Boston Only illustrative examples

Normal

Infarct

Viability

Hibernation

Cardiomyopathy

In reality what it looks like

Improving the system Can we use PET to provide a better service Rb-82 may allow for faster more accurat imaging Possibly all can be performed in a (one stop shop) Especially with 64 or 128 slice CT

Rb-82 for perfusion Bateman et al Kansas JNC 2006 112 patients had Tc-99m MIBI and Rb-82 perfusion studies 4 blinded readers compared results with CABG (stenosis of 70%) Rb-82 had accuracy of 89% compared with 79% for SPECT (p=0.003) Rb-82 better in men and the obese

J Machac NYU SPECT vs Rb-82 PET

AC vs PET

Proposed scheme for viability AC CT AC-CT AC-CT CT angiogram Rb-82 injection and scan F-18 FDG injection FDG scan adenosine stress 0 15 30 45 60 90 120 135 150 mins 18mSv without CT angiogram 42mSv with CT angiogram

What else can we do with PET Look at fatty acid uptake which may be the first change to occur with ischaemia C-11 acetate Look at deposition of Ca in placques more specific to ongoing process than CT Na-F-18 CAFÉ project Look at hypoxia directly with F-18 FMISO or Cu-64 ATSM

C-11 acetate in the heart

PET and CT Wagner et al Munich JACC 2007 Used a combination of PET and CT to look at structure and function in the treatment of ischaemia by transgenic infection with adenovirus Able to use combination to determine both cardiac anatomy and function and result of genetic treatment

Able to show reporter gene function and perfusion with PET

Peripheral CVS Atherosclerosis can occur in most major vessels Can be linked to embolism and thrombosis Known linkage to chol New evidence inflammed atheroma most unstable Can be treated with statins

Figuerola et al Circ Imaging 2011

Arterial FDG Signal Is Reproducible Day 1 Day 14 Rudd JHF et al JACC 2007 Rudd JHF et al JNM 2008

Response To Therapy: Simvastatin Treatment Study Tahara et al JACC 2006

In conclusion PET imaging is able to identify viability Probably best combination is Rb-82 (or N-13 NH 3 ) and F-18 FDG PET Can be used to predict response to surgery How does PET results compare with MR? New role of PET in peripheral CV disease